TY - JOUR AU - Li, Qing AU - Wang, Ying AU - Sun, Qiang AU - Knopf, Jasmin AU - Herrmann, Martin AU - Lin, Liangyu AU - Jiang, Jingting AU - Shao, Changshun AU - Li, Peishan AU - He, Xiaozhou AU - Hua, Fei AU - Niu, Zubiao AU - Ma, Chaobing AU - Zhu, Yichao AU - Ippolito, Giuseppe AU - Piacentini, Mauro AU - Estaquier, Jerome AU - Melino, Sonia AU - Weiss, Felix Daniel AU - Andreano, Emanuele AU - Latz, Eicke AU - Schultze, Joachim AU - Rappuoli, Rino AU - Mantovani, Alberto AU - Mak, Tak Wah AU - Melino, Gerry AU - Shi, Yufang TI - Immune response in COVID-19: what is next? JO - Cell death and differentiation VL - 29 SN - 1350-9047 CY - London PB - Macmillan M1 - DZNE-2022-00718 SP - 1107-1122 PY - 2022 N1 - (CC BY) AB - The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. KW - COVID-19 KW - COVID-19 Vaccines KW - Humans KW - Immunity, Innate KW - Pandemics: prevention & control KW - SARS-CoV-2 LB - PUB:(DE-HGF)16 C6 - pmid:35581387 C2 - pmc:PMC9110941 DO - DOI:10.1038/s41418-022-01015-x UR - https://pub.dzne.de/record/164055 ER -